Event Videos

https://pubmed.ncbi.nlm.nih.gov/33399331/ NAFLD

J Pediatr Gastroenterol Nutr. 2020 Dec 30;Publish Ahead of Print. doi: 10.1097/MPG.0000000000003040. Online ahead of print
.
Dairy Fat Intake, Plasma C15: 0 and Plasma Iso-C17: 0 are Inversely Associated with Liver Fat in Children

Mary Catherine Sawh 1 , Martina Wallace, Emma Shapiro, Nidhi P Goyal, Kimberly P Newton, Elizabeth L Yu, Craig Bross, Janis Durelle, Cynthia Knott, Jon A Gangoiti, Bruce A Barshop, Jivani M Gengatharan, Noah Meurs, Alexandra Schlein, Michael S Middleton, Claude B Sirlin, Christian M Metallo, Jeffrey B Schwimmer

Abstract

Published on: 
Dec-2020

https://pubmed.ncbi.nlm.nih.gov/33505894/ NAFLD
Pediatr Gastroenterol Hepatol Nutr. 2021 Jan;24(1):54-64.
doi: 10.5223/pghn.2021.24.1.54. Epub 2021 Jan 8.

Changes in Liver Enzymes and Metabolic Profile in Adolescents with Fatty Liver following Exercise Interventions

Hamdollah Iraji 1, Vazgen Minasian 1, Roya Kelishadi 2

Abstract

Purpose: Nonalcoholic fatty liver disease (NAFLD) is the most frequent cause of chronic liver diseases in both adults and children with obesity. The aim of this study was to compare the changes in liver enzymes and metabolic profile in adolescents with fatty liver following selected school-based exercise (SBE) and high-intensity interval training (HIIT) interventions.

Published on: 
Jan-2021

https://pubmed.ncbi.nlm.nih.gov/33399328/ hepatitis b

J Pediatr Gastroenterol Nutr. 2020 Dec 30;Publish Ahead of Print. doi: 10.1097/MPG.0000000000003042. Online ahead of print.
Management of Hepatitis-B Virus Infection in Immunocompromised Children. A Single Center Experience

Pier Luigi Calvo 1 , Michele Pinon, Dominic Dell'Olio, Andrea Carpino, Eleonora Biasin, Antonio Pizzol, Silvia Catalano, Licia Peruzzi, Caterina Rigazio, Fabio Cisarò, Anna Opramolla, Sebastian Dorin Asaftei, Paola Quarello, Franca Fagioli

Abstract

Objectives: To expand the pediatric experience on Hepatitis-B Virus (HBV) reactivation, a known complication in patients with hematologic malignancies or on immunosuppression.

Published on: 
Dec-2020

https://pubmed.ncbi.nlm.nih.gov/33500120/ Autoimmune Hepatitis
J Pediatr. 2021 Feb;229:95-101.e3.
doi: 10.1016/j.jpeds.2020.10.009. Epub 2020 Oct 23.

Autoimmune Hepatitis: Predictors of Native Liver Survival in Children and Adolescents

Gilda Porta 1, Elisa de Carvalho 2, Jorge L Santos 3, Jorge Gama 4, Jorge A Bezerra 5, Brazilian Group for the Study of Pediatric Liver Diseases

Abstract

Objective: To determine predictors of native liver survival (NLS) in children and adolescents with autoimmune hepatitis (AIH).
Study design: The medical records of children and adolescents with AIH were reviewed. A questionnaire was used to collect data on clinical presentation, biochemical and histologic findings, and treatment.

Published on: 
Jan-2021

https://pubmed.ncbi.nlm.nih.gov/33388243/ EHPVO

Review
HPB (Oxford). 2020 Dec 30;S1365-182X(20)32394-7. doi: 10.1016/j.hpb.2020.11.1149. Online ahead of print.

Surgical shunts for extrahepatic portal vein obstruction in pediatric patients: a systematic review

Shannon Zielsdorf 1 , Lalita Narayanan 2 , Sophia Kantymyr 2 , Arianna Barbetta 3 , Yong Kwon 4 , Kambiz Etesami 4 , Yuri Genyk 4 , Juliet Emamaullee 4

Abstract

Published on: 
Dec-2020

https://pubmed.ncbi.nlm.nih.gov/33425821/ Acute liver failure
Review
Front Pediatr. 2020 Dec 23;8:618119. doi: 10.3389/fped.2020.618119. eCollection 2020.

Hemostatic Balance in Pediatric Acute Liver Failure: Epidemiology of Bleeding and Thrombosis, Physiology, and Current Strategies

Yonca Bulut 1 , Anil Sapru 1 , Gavin D Roach 2

Abstract

Published on: 
Dec-2020

https://pubmed.ncbi.nlm.nih.gov/33368446/ NAFLD

Editorial
Hepatology. 2020 Dec 25. doi: 10.1002/hep.31696. Online ahead of print.

To Juice or Not to Juice: Fatty Liver Repercussions for Infants

Matthew D Di Guglielmo 1 , Emily R Perito 2

Abstract

As the obesity epidemic marches on, comorbid diagnoses arrive earlier in life. In children, the main liver manifestation of this epidemic is nonalcoholic fatty liver disease (NAFLD), now the most common cause of chronic liver disease worldwide, with the staggering prediction that its progression has become the leading cause of end-stage liver disease.

Published on: 
Dec-2020

https://pubmed.ncbi.nlm.nih.gov/33414089/ Cholestasis

J Clin Lipidol. 2020 Dec 14;S1933-2874(20)30341-X. doi: 10.1016/j.jacl.2020.12.004. Online ahead of print.

Cholestasis as a dominating symptom of patients with CYP27A1 mutations: An analysis of 17 Chinese infants

Ping Zhang 1 , Jing Zhao 2 , Xiao-Min Peng 1 , Yan-Yan Qian 1 , Xue-Mei Zhao 1 , Wen-Hao Zhou 3 , Jian-She Wang 2 , Bing-Bing Wu 4 , Hui-Jun Wang 5

Abstract

Background: CYP27A1 is the disease-causing gene of cerebrotendinous xanthomatosis (CTX). As a treatable lipid storage disease, early treatment can improve the prognosis. However, CTX patients reported in the literature are mostly adult patients; the phenotype spectrum of CTX in the infantile population remains elusive.

Published on: 
Dec-2020

CLF Intro movie

Financial Aid Offered by Trusts

Follow us on: